Does TIPIRACIL\TRIFLURIDINE Cause Hyperkeratosis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperkeratosis have been filed in association with TIPIRACIL\TRIFLURIDINE. This represents 0.1% of all adverse event reports for TIPIRACIL\TRIFLURIDINE.
7
Reports of Hyperkeratosis with TIPIRACIL\TRIFLURIDINE
0.1%
of all TIPIRACIL\TRIFLURIDINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hyperkeratosis From TIPIRACIL\TRIFLURIDINE?
Of the 7 reports, 4 (57.1%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIPIRACIL\TRIFLURIDINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TIPIRACIL\TRIFLURIDINE Cause?
Death (3,017)
Disease progression (1,774)
Fatigue (1,298)
Nausea (1,135)
Diarrhoea (965)
Decreased appetite (659)
Vomiting (628)
White blood cell count decreased (483)
Asthenia (472)
Anaemia (388)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which TIPIRACIL\TRIFLURIDINE Alternatives Have Lower Hyperkeratosis Risk?
TIPIRACIL\TRIFLURIDINE vs TIPRANAVIR
TIPIRACIL\TRIFLURIDINE vs TIRAGOLUMAB
TIPIRACIL\TRIFLURIDINE vs TIRBANIBULIN
TIPIRACIL\TRIFLURIDINE vs TIROFIBAN
TIPIRACIL\TRIFLURIDINE vs TIRZEPATIDE